New Life Science Study Findings Have Been Reported by Researchers at University of Miami (Zurletrectinib Is a Next-generation Trk Inhibitor With Strong Intracranial Activity Against ntrk Fusion-positive Tumours With On-target Resistanc

    Press/Media: Press / Media

    PeriodJul 11 2024

    Media coverage

    1

    Media coverage

    • TitleNew Life Science Study Findings Have Been Reported by Researchers at University of Miami (Zurletrectinib Is a Next-generation Trk Inhibitor With Strong Intracranial Activity Against ntrk Fusion-positive Tumours With On-target Resistanc
      Media name/outletGenomics & Genetics Daily
      Country/TerritoryUnited States
      Date07/11/24
      PersonsBin Zhang